Cheshire, CT, United States of America

Xiaofan Zheng

USPTO Granted Patents = 26 

 

Average Co-Inventor Count = 5.3

ph-index = 8

Forward Citations = 226(Granted Patents)


Location History:

  • Meriden, CT (US) (2001 - 2003)
  • Cheshire, CT (US) (2004 - 2024)

Company Filing History:


Years Active: 2001-2024

Loading Chart...
Loading Chart...
26 patents (USPTO):Explore Patents

Title: **Xiaofan Zheng: A Leader in T Cell Activator Innovations**

Introduction

Xiaofan Zheng, a prolific inventor based in Cheshire, CT, holds an impressive portfolio comprising 26 patents. His work primarily focuses on developing innovative compounds beneficial in treating viral infections and proliferative disorders, such as cancer. Zheng's contributions are significant in the field of biochemistry and pharmacology, paving the way for novel therapeutic approaches.

Latest Patents

Among his latest patents are the groundbreaking inventions related to naphthyridinone compounds, which serve as T cell activators. These compounds, represented by Formula (I), include methods designed to inhibit the activity of diacylglycerol kinase alpha (DGK α) and diacylglycerol kinase zeta (DGK ζ). Both patents reveal the potential of these compounds in creating pharmaceutical compositions that could play a crucial role in treating viral infections and various forms of cancer.

Career Highlights

Xiaofan Zheng has made significant strides in his career, most notably during his tenure at Bristol-Myers Squibb Company. His experience in this renowned pharmaceutical company has equipped him with the expertise needed to innovate in drug development and deployment. His innovations have garnered attention in the field, showcasing his commitment to advancing medical science.

Collaborations

Throughout his career, Zheng has collaborated with respected professionals, including Thomas W. Hudyma and Min Ding. These partnerships highlight the importance of teamwork in driving research and development efforts, ultimately leading to vital breakthroughs in healthcare solutions.

Conclusion

Xiaofan Zheng's impactful work in developing naphthyridinone compounds as T cell activators positions him as a key figure within the biotechnology landscape. With 26 patents to his name and a history of collaboration with prominent figures in the industry, his contributions continue to pave the way for innovations in treating serious health conditions. Zheng's dedication to research and development will undoubtedly inspire future generations of scientists and inventors in the quest for new therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…